Xanthomatosis: Clinical Trials

29 trials for Xanthomatosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 7 unknown, 4 recruiting, 2 active not recruiting. 8 Not applicable, 3 Phase 3, 2 Phase 1, 2 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 2, Unknown 2, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1, Withdrawn 1
Phase 33Completed 2, Withdrawn 1
Phase 12Completed 1, Terminated 1
Phase 22Not yet recruiting 1, Unknown 1
Phase 41Completed 1

Follow Xanthomatosis: new trials by email Literature Review of Xanthomatosis trials Research Report on Xanthomatosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical 2% Simvastatin for Xanthelasma Palpebrarum
Topical Simvastatin 2% Cream, Vehicle cream - Xanthelasma Palpebrarum
Phase 2Not yet recruitingKlira Skin302026-08-012026-06-23
Observation of the Effect and Mechanism of Multi Tunnel Minimally Invasive Treatment for Xanthelasma Palpebrarum
Multi level and multi tunnel puncture treatment, Heparin Sodium Injection, Multi Level and Multi Tunnel Puncture Treatment + Heparin Sodium Injection - Xanthelasma Palpebrarum
Not applicableEnrolling by invitationFuzhou First General Hospital Skin Disease Prevention and Control Hospital2702025-02-012025-03-11
''Comparative Evaluation of Change in Bite Force and Levels of Bone Turnover Markers CTX and BALP in Hyperdivergent and Hypodivergent Cases During Retention Phases-A Prospective Clinical Trial ''
Bite force and Gcf - Relapse, Bite Force
Not applicableRecruitingPostgraduate Institute of Dental Sciences Rohtak402024-12-252024-12-10
Efficacy of 100% Trichloroacetic Acid Vs. Cryotherapy in Xanthelasma Palpebrarum
100% Trichloroacetic Acid (TCA), Cryotherapy (Liquid Nitrogen) - Xanthelasma Palpebrarum
Not applicableActive not recruitingNishtar Medical University602024-09-072025-02-21
A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX)
Chenodeoxycholic acid, Chenodeoxycholic acid Placebo - Cerebrotendinous Xanthomatoses
Phase 3WithdrawnLeadiant Biosciences, Inc.2024-05-272024-11-18
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Ultra-pulsed Carbon Dioxide Laser - Eyelid Tumor, Xanthelasma Palpebrarum
UnknownSun Yat-sen University10002022-11-012024-03-07
Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxycholic Acid Leadiant 250 mg Hard Capsules (250mg Chenodeoxycholic Acid)
Chenodeoxycholic acid, Chenodeoxycholic acid leadiant - Cerebrotendinous Xanthomatoses
Phase 1CompletedHumanis Saglık Anonim Sirketi242022-06-122023-12-28
Atorvastatin Therapy on Xanthoma in Alagille Syndrome
atorvastatin - Alagille Syndrome, Atorvastatin
Phase 4CompletedChildren's Hospital of Fudan University152022-03-222026-03-27
Type I Collagen Fragments in the GCF and Saliva During OTM
Biological measuring of collagen fragments biomarker during orthodontic tooth movement - Collagen Degeneration
Not applicableUnknownAlexandria University142021-05-152021-08-27
ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
Confirmatory Testing - Acid Sphingomyelinase Deficiency, Ceroid Lipofuscinosis, Neuronal, 2
Enrolling by invitationAlbert Einstein College of Medicine1000002021-05-102026-07-28
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
collection of data - Inherited Disease, Rare Diseases
RecruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1002021-03-012024-11-19
Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)
Blinded CDCA 250 mg TID, Placebo, Open-Label CDCA 250 mg TID - CTX
Phase 3CompletedMirum Pharmaceuticals, Inc.192020-01-312024-10-28
A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX)
Mutation Analysis - Xanthomatosis, Cerebrotendinous
UnknownTRPHARM8002019-12-012021-04-01
An Observational Study for Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease
Blood sampling for cholestanol analysis - CTX - Cerebrotendinous Xanthomatosis
TerminatedTRPHARM222019-10-192022-06-15
Early Check: Expanded Screening in Newborns
Confirmatory Testing - Spinal Muscular Atrophy, Fragile X Syndrome
Active not recruitingRTI International300002018-10-152026-07-01
Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism.
Liquid meal (Nutridrink), GIP, GLP-2 - Hypoparathyroidism
Not applicableCompletedUniversity of Copenhagen72018-09-122019-12-12
Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)
TTRNA-DC vaccines with GM-CSF, TTRNA-xALT, Cyclophosphamide + Fludarabine Lymphodepletive Conditioning - Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma
Phase 1TerminatedUniversity of Florida112018-07-172025-10-29
The Prevalence of CTX Disorder in Juvenile Cataract Cases in Turkey
Blood sampling for Cholestanol Analysis - Cerebrotendinous Xanthomatosis
UnknownTRPHARM10002018-06-012021-03-29
Investigation for Health Efficacy of Infrared-C Radiation on Diabetes Patients in Senior's Activity Center
FIR-C mattress, FIR-C abdominal pad, fake FIR-C mattress - Diabetes Mellitus, Type 2
Not applicableUnknownNanhua University642018-03-232019-11-26
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
Leukodystrophy, White Matter Disease
CompletedChildren's Hospital of Philadelphia2362017-01-062025-11-10

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Xanthomatosis, Cerebrotendinous (23)  ·  Leukodystrophy, Metachromatic (5)  ·  Leukodystrophy, Globoid Cell (4)  ·  Adrenoleukodystrophy (3)  ·  Alexander Disease (3)  ·  Canavan Disease (3)  ·  Leukoencephalopathies (3)  ·  Pelizaeus-Merzbacher Disease (3)  ·  Peroxisomal Disorders (3)  ·  Rare Diseases (3)  ·  Aicardi-Goutieres syndrome (2)  ·  Alexanders leukodystrophy (2)  ·  Allan-Herndon-Dudley syndrome (2)  ·  Attention Deficit Disorder with Hyperactivity (2)

Broader conditions

Lipid Metabolism Disorders (29)  ·  Nutritional and Metabolic Diseases (29)  ·  Metabolic Diseases (28)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (24)  ·  Genetic Diseases, Inborn (23)  ·  Lipid Metabolism, Inborn Errors (23)  ·  Metabolism, Inborn Errors (22)  ·  Pathologic Processes (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Brain Diseases (6)  ·  Cardiovascular Diseases (6)  ·  Central Nervous System Diseases (6)  ·  Endocrine System Diseases (6)  ·  Skin and Connective Tissue Diseases (6)

Interventions

Chenodeoxycholic Acid (5)  ·  Blood Specimen Collection (2)  ·  Atorvastatin (1)  ·  Bite Force (1)  ·  Cryotherapy (1)  ·  Cyclophosphamide (1)  ·  Diphtheria-Tetanus Vaccine (1)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (1)  ·  Hematologic Tests (1)  ·  Heparin (1)  ·  Lasers, Gas (1)  ·  Lovastatin (1)  ·  Simvastatin (1)  ·  Sodium Chloride (1)  ·  Teriparatide (1)

Sponsors

TRPHARM (3)  ·  Children's Hospital of Philadelphia (2)  ·  Albert Einstein College of Medicine (1)  ·  Alexandria University (1)  ·  Children's Hospital of Fudan University (1)  ·  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1)  ·  Fuzhou First General Hospital Skin Disease Prevention and Control Hospital (1)  ·  Humanis Saglık Anonim Sirketi (1)  ·  Joint Authority for Päijät-Häme Social and Health Care (1)  ·  Klira Skin (1)  ·  Leadiant Biosciences Ltd. (1)  ·  Leadiant Biosciences, Inc. (1)  ·  Mirum Pharmaceuticals, Inc. (1)  ·  Nanhua University (1)  ·  National Center for Research Resources (NCRR) (1)

Countries

United States (11)  ·  China (3)  ·  Turkey (Türkiye) (3)  ·  Germany (2)  ·  Israel (2)  ·  Italy (2)  ·  Spain (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Finland (1)

Top investigators

Adeline Vanderver, MD (2)  ·  Ching Yong Chin, Master (1)  ·  Curt Scharfe, MD, PhD (1)  ·  Elias Sayour, MD, PhD (1)  ·  Erna Snellman, professor (1)  ·  Gerald Salen (1)  ·  Hasan Onal, Asc. Prof. (1)  ·  Hofit Cohen, MD (1)  ·  Jin-Bang Shang, Master (1)  ·  Melissa Wasserstein, MD (1)  ·  Mette Rosenkilde, MD (1)  ·  Muhammad Irfan Jamil (1)  ·  Omar Tareq (1)

Results publications

PMID 19602651, PMID 31315600, PMID 32342562, PMID 32749716, PMID 35142618, PMID 37782421, PMID 41667276, PMID 9492234

NIH funding

2019 (1), 2023 (1), R01HD073292 (1), U01NS106845 (1), U54NS115052 (1)